论文部分内容阅读
目的观察运用超早期微创穿刺引流术治疗高血压脑出血的疗效,探讨其在临床治疗中的应用价值。方法回顾性分析医院收治的59例高血压脑出血患者的临床资料,根据实施手术时机的不同分为超早期组(发病7 h以内施行手术者)32例,延期组(发病7~72 h施行手术者)27例,观察比较2组患者的临床治疗效果。结果2组患者术后并发症发生率及病死率比较,差异均无统计学意义(P>0.05)。治疗6个月后,超早期组格拉斯哥预后量表(GOS)预后优良率为59.38%,高于延期组的29.63%(P<0.05)。结论超早期微创穿刺引流术治疗高血压脑出血的临床效果肯定,可提高患者GOS评分预后优良率,值得临床推广应用。
Objective To observe the effect of ultra-early minimally invasive puncture drainage on hypertensive intracerebral hemorrhage and to explore its clinical value. Methods The clinical data of 59 patients with hypertensive intracerebral hemorrhage admitted in the hospital were retrospectively analyzed. According to the different operation timing, 32 cases were divided into ultra early group (operation within 7 hours after onset), 32 cases delayed from 7 to 72 hours Surgery), 27 cases were observed and compared the clinical efficacy of the two groups of patients. Results There was no significant difference in postoperative morbidity and mortality between the two groups (P> 0.05). After 6 months of treatment, the excellent and good prognosis of the Glasgow Outcome Scale (GOS) was 59.38%, higher than that of the delayed group (29.63%, P <0.05). Conclusion Ultra-early minimally invasive puncture and drainage for the treatment of hypertensive intracerebral hemorrhage certainly clinical effect, can improve the prognosis of patients with GOS score excellent rate, worthy of clinical application.